BICX
Price:
$0.34
Market Cap:
$5.78M
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addi...[Read more]
Industry
Medical - Care Facilities
IPO Date
2010-08-31
Stock Exchange
OTC
Ticker
BICX
According to BioCorRx Inc.’s latest financial reports and current stock price. The company's current ROE is 40.30%. This represents a change of 299.27% compared to the average of 10.09% of the last 4 quarters.
The mean historical ROE of BioCorRx Inc. over the last ten years is 219.92%. The current 40.30% ROE has changed -81.67% with respect to the historical average. Over the past ten years (40 quarters), BICX's ROE was at its highest in in the December 2019 quarter at 122.61%. The ROE was at its lowest in in the September 2019 quarter at -1129.80%.
Average
219.92%
Median
91.42%
Minimum
38.35%
Maximum
788.40%
Discovering the peaks and valleys of BioCorRx Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 950.81%
Maximum Annual ROE = 788.40%
Minimum Annual Increase = -113.92%
Minimum Annual ROE = 38.35%
Year | ROE | Change |
---|---|---|
2024 | 42.13% | 9.87% |
2023 | 38.35% | -29.12% |
2022 | 54.10% | -36.20% |
2021 | 84.80% | -13.52% |
2020 | 98.05% | -87.56% |
2019 | 788.40% | 582.10% |
2018 | 115.58% | -84.85% |
2017 | 763.07% | 950.81% |
2016 | 72.62% | -48.91% |
2015 | 142.13% | -113.92% |
The current ROE of BioCorRx Inc. (BICX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.86%
5-year avg
63.48%
10-year avg
219.92%
BioCorRx Inc.’s ROE is greater than Bionik Laboratories Corp. (-768.84%), less than Guided Therapeutics, Inc. (77.98%), less than RegeneRx Biopharmaceuticals, Inc. (60.88%), less than Saker Aviation Services, Inc. (6.05%),
Company | ROE | Market cap |
---|---|---|
-768.84% | $1.25K | |
77.98% | $16.57M | |
60.88% | $181.13K | |
6.05% | $8.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCorRx Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioCorRx Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioCorRx Inc.'s ROE?
How is the ROE calculated for BioCorRx Inc. (BICX)?
What is the highest ROE for BioCorRx Inc. (BICX)?
What is the 3-year average ROE for BioCorRx Inc. (BICX)?
What is the 5-year average ROE for BioCorRx Inc. (BICX)?
How does the current ROE for BioCorRx Inc. (BICX) compare to its historical average?